Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire

Clinical trial NCT07069439 · COMPLETED

Trial details

NCT number: NCT07069439
Sponsor: Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Status: COMPLETED
Study type: OBSERVATIONAL

Drug Hypersensitivity Quality of Life (QOL)Caregivers Allergy and Immunology

Start date: 2025-08-01
Primary completion: 2025-10-30
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.